Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
UNIVERSITY OF LIVERPOOL has floated a tender for Gb-Liverpool: Glp Toxicology Evaluation of Long-Acting Injectable (Lai) Products for Ltbi Prevention and Hcv Cure. The project location is United Kingdom and the tender is closing on 01 Apr 2024. The tender notice number is BIP845905974, while the TOT Ref Number is 97999055. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : United Kingdom
Summary : Gb-Liverpool: Glp Toxicology Evaluation of Long-Acting Injectable (Lai) Products for Ltbi Prevention and Hcv Cure
Deadline : 01 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 97999055
Document Ref. No. : BIP845905974
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : GBP 500000
Purchaser's Detail
Purchaser : UNIVERSITY OF LIVERPOOL
Procurement Foundation Building Liverpool L69 7ZX UK
Contact Person : Ann Bickerstaffe
United Kingdom
Email :bickera@liverpool.ac.uk
Tender Details
Title : GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure
Location Of Contract : North West
Industry : Research laboratory services - 73111000
Value Of Contract : £100, 000 to £500, 000
Description : The University of Liverpool, through its LONGEVITY project funded by Unitaid, is implementing product development and commercialization of Long-Acting Injectable (LAI) formulations for malaria and tuberculosis prevention, and a hepatitis C virus cure for Low- and Middle-Income Countries (LMIC's). The University of Liverpool was awarded 32 million US dollars in early 2020 from Unitaid (https://unitaid.org/) as part of the 40 million US dollar project to fund these activities to commercialisation.https://unitaid.org/news-blog/unitaid-invests-in-long-acting-medicines-to-simplify-treatment-and-prevention-for-hiv-tb-malaria-and-hcv/#en https://www.liverpool.ac.uk/chemistry/news/articles/24m-boost-for-revolutionary-long-acting-medicine-research/ The TB and HCV products are reaching the end of proof-of-concept studies and the University of Liverpool is seeking quotations for provision of GLP toxicology services to support product clinical stage progress. Full outline of study requirements available from the University of Liverpool's tendering website (details included in other information section below)
Published Date : 1 March 2024
Closing Date :...
Documents
Want To Bid in This Tender?
Get Local Agent Support in United Kingdom and 60 More Countries.
View Tenders By
Sign in with Google